Search Results - Robey, Rebecca

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus

    The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus by Robey, Rebecca C., Mletzko, Salvinia, Gotch, Frances M.

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy

    Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy by Tewkesbury, Daniel H., Robey, Rebecca C., Barry, Peter J.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells

    Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells by Matthews, Nick C, Goodier, Martin R, Robey, Rebecca C, Bower, Mark, Gotch, Frances M

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Chicken interferome: avian interferon-stimulated genes identified by microarray and RNA-seq of primary chick embryo fibroblasts treated with a chicken type I interferon (IFN-α)

    Chicken interferome: avian interferon-stimulated genes identified by microarray and RNA-seq of primary chick embryo fibroblasts treated with a chicken type I interferon (IFN-α) by Giotis, Efstathios S., Robey, Rebecca C., Skinner, Natalie G., Tomlinson, Christopher D., Goodbourn, Stephen, Skinner, Michael A.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

    Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study by Mletzko, Salvinia, Pinato, David J., Robey, Rebecca C., Dalla Pria, Alessia, Benson, Peter, Imami, Nesrina, Bower, Mark

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Genetic Screen of a Mutant Poxvirus Library Identifies an Ankyrin Repeat Protein Involved in Blocking Induction of Avian Type I Interferon

    Genetic Screen of a Mutant Poxvirus Library Identifies an Ankyrin Repeat Protein Involved in Blocking Induction of Avian Type I Interferon by Laidlaw, Stephen M., Robey, Rebecca, Davies, Marc, Giotis, Efstathios S., Ross, Craig, Buttigieg, Karen, Goodbourn, Stephen, Skinner, Michael A.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus’ Lateral Body Protein

    Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus’ Lateral Body Protein by Giotis, Efstathios S., Laidlaw, Stephen M., Bidgood, Susanna R., Albrecht, David, Burden, Jemima J., Robey, Rebecca C., Mercer, Jason, Skinner, Michael A.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens

    The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens by Robey, Rebecca C., Lagos, Dimitrios, Gratrix, Fiona, Henderson, Stephen, Matthews, Nick C., Vart, Richard J., Bower, Mark, Boshoff, Chris, Gotch, Frances M.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service

    Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service by Robey, Rebecca C., Kemp, Katie, Hayton, Philip, Mudawi, Dalia, Wang, Ran, Greaves, Melanie, Yioe, Veronica, Rivera-Ortega, Pilar, Avram, Cristina, Chaudhuri, Nazia

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Toll-like Receptor 4 Mediates Innate Immunity to Kaposi Sarcoma Herpesvirus

    Toll-like Receptor 4 Mediates Innate Immunity to Kaposi Sarcoma Herpesvirus by Lagos, Dimitrios, Vart, Richard James, Gratrix, Fiona, Westrop, Samantha Jane, Emuss, Victoria, Wong, Ping-Pui, Robey, Rebecca, Imami, Nesrina, Bower, Mark, Gotch, Frances, Boshoff, Chris

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Large scale clinical trials: lessons from the COVID-19 pandemic

    Large scale clinical trials: lessons from the COVID-19 pandemic by Horsley, Alex R, Pearmain, Laurence, Knight, Sean, Schindler, Nick, Wang, Ran, Bennett, Miriam, Robey, Rebecca C, Davies, Jane C, Djukanović, Ratko, Heaney, Liam G, Hussell, Tracy, Marciniak, Stefan J, McGarvey, Lorcan P, Porter, Joanna, Wilkinson, Tom, Brightling, Chris, Ho, Ling-Pei

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: